BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.
Industry, Sector and Symbol:
- Sector: Finance
- Industry: REIT - Office
- Sub-Industry: Office REITs
- Symbol: NYSE:BMR
- CUSIP: 09063H10
- Web: N/A
- Market Cap: $4.81 billion
- Outstanding Shares: 202,210,000
- 50 Day Moving Avg: $24.00
- 200 Day Moving Avg: $22.00
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 15.77
- P/E Growth: 0
Frequently Asked Questions for Biomed Realty Trust (NYSE:BMR)
What is Biomed Realty Trust's stock symbol?
Biomed Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BMR."
How were Biomed Realty Trust's earnings last quarter?
Biomed Realty Trust Inc (NYSE:BMR) issued its earnings results on Tuesday, April, 28th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.37 by $0.04. The company earned $178.01 million during the quarter, compared to the consensus estimate of $167.08 million. The firm's revenue for the quarter was up 5.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.38 EPS. View Biomed Realty Trust's Earnings History.
Who are some of Biomed Realty Trust's key competitors?
Some companies that are related to Biomed Realty Trust include Kilroy Realty Corp (KRC), Liberty Property Trust (LPT), Highwoods Properties (HIW), Hudson Pacific Properties (HPP), Gramercy Property Trust (GPT), DuPont Fabros Technology (DFT), Equity Commonwealth (EQC), CoreSite Realty Corp (COR), Corporate Office Properties Trust (OFC), Piedmont Office Realty Trust (PDM), Columbia Property Trust (CXP), Washington Real Estate Investment Trust (WRE), Mack Cali Realty Corp (CLI), Brookfield Canada Office Properties (BOXC), Select Income REIT (SIR), Government Properties Income Trust (GOV), New York REIT (NYRT) and Parkway (PKY).
How do I buy Biomed Realty Trust stock?
Shares of Biomed Realty Trust can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Biomed Realty Trust stock cost?
One share of Biomed Realty Trust stock can currently be purchased for approximately $23.81.
Earnings History for Biomed Realty Trust (NYSE:BMR)Earnings History by Quarter for Biomed Realty Trust (NYSE:BMR)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/28/2015||Q115||$0.37||$0.41||$167.08 million||$178.01 million||View||Listen|
|8/5/2014||Q214||$0.36||$0.40||$160.80 million||$171.16 million||View||Listen|
|8/7/2013||Q213||$0.39||$0.37||$143.47 million||$159.64 million||View||Listen|
|2/6/2013||Q412||$0.34||$0.36||$134.72 million||$138.80 million||View||Listen|
|11/1/2012||Q312||$0.33||$0.34||$130.32 million||$134.54 million||View||N/A|
Earnings Estimates for Biomed Realty Trust (NYSE:BMR)
Current Year EPS Consensus Estimate: $1.77 EPS
Next Year EPS Consensus Estimate: $1.51 EPS
Current Dividend Information for Biomed Realty Trust (NYSE:BMR)
|Most Recent Dividend:||10/15/2015|
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||0.00% (Based on This Year's Estimates)|
0.00% (Based on Next Year's Estimates)
|Track Record:||7 Years of Consecutive Dividend Growth|
Dividend History by Quarter for Biomed Realty Trust (NYSE:BMR)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Biomed Realty Trust (NYSE:BMR)Insider Trades by Quarter for Biomed Realty Trust (NYSE:BMR)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/17/2015||John P Bonanno||EVP||Sell||4,800||$21.01||$100,848.00|| |
|6/15/2015||James R Berens||Insider||Sell||2,000||$19.99||$39,980.00|| |
|6/15/2015||John P Bonanno||EVP||Sell||5,000||$19.85||$99,250.00|| |
|3/16/2015||Margaret Faye Wilson||Director||Buy||2,300||$21.76||$50,048.00|| |
|9/8/2014||Stephen A Willey||CAO||Sell||1,388||$22.50||$31,230.00|| |
|8/13/2014||Alan D Gold||CEO||Sell||26,615||$22.17||$590,054.55|| |
|8/13/2014||Matthew G Mcdevitt||VP||Sell||16,000||$22.01||$352,160.00|| |
|6/3/2014||Matthew G Mcdevitt||VP||Sell||7,000||$21.91||$153,370.00|| |
|5/14/2014||Alan Gold||CEO||Sell||25,000||$21.18||$529,500.00|| |
|5/12/2014||Stephen Willey||CAO||Sell||4,840||$21.00||$101,640.00|| |
|3/11/2014||Stephen Willey||CAO||Sell||7,931||$20.25||$160,602.75|| |
|2/11/2014||Matthew Mcdevitt||VP||Sell||60,000||$20.28||$1,216,800.00|| |
|11/23/2012||Matthew G Mcdevitt||VP||Sell||5,223||$19.05||$99,498.15|| |
Headline Trends for Biomed Realty Trust (NYSE:BMR)
Latest Headlines for Biomed Realty Trust (NYSE:BMR)
Biomed Realty Trust (BMR) Chart for Sunday, May, 28, 2017